-
Featured
Using Genetics and Big Data to Determine Risk for Developing Glaucoma
Nazlee Zebardast, MD, MSc, director of Glaucoma Imaging at Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, discusses the use of big data to determine endophenotypes for disease in glaucoma.
-
Non-invasive OCTA Imaging Biomarker Tied to Neovascular Glaucoma in Patients With Proliferative Diabetic Retinopathy
John B. Miller, MD, Edward S. Lu, MD, and colleagues found retinal ischemia on widefield swept-source optical coherence tomography angiography was associated with 13-fold increased odds of neovascular glaucoma, a vision-threatening complication in patients with proliferative diabetic retinopathy.
-
Integrated Genomic Analysis Prioritizes Causal Genes and Cell Types for Glaucoma
Ayellet V. Segrè, PhD, MSc, and colleagues integrated multiple genetic and functional genomic datasets and identified regulatory mechanisms, genes, pathways and cell types that may play an important role in the etiology of primary open-angle glaucoma and become targets for novel therapies.
-
Mass Eye and Ear Ophthalmology: Celebrating 200 Years of Excellence in Patient Care, Research, and Education
This year, Mass Eye and Ear is celebrating its 200th anniversary. To kick things off, we are highlighting some of the ophthalmology department’s most significant achievements in patient care, research, and education.
-
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
Researchers at Mass Eye and Ear, led by Nazlee Zebardast, MD, MSc, examined six years of nationwide U.S. data on standard and minimally invasive glaucoma surgery. They found that the specific glaucoma diagnosis influences the choice of procedure, as well as concurrent and subsequent surgeries.
-
Van Herick Grading Not a Useful Screening Tool on Population Level
David S. Friedman, MD, PhD, MPH, and colleagues found that van Herick grading of limbal anterior chamber depth may be useful for identifying iridotrabecular contact, but a relatively high false positive rate limits its usefulness for community-based screening for primary angle closure.
Glaucoma Contributors
-
David S. Friedman, MD, PhD, MPH
Director, Glaucoma Service, Albert and Diane Kaneb Chair in Ophthalmology, Mass Eye and Ear, Professor, Ophthalmology, Harvard Medical School
Recent Article
Van Herick Grading Not a Useful Screening Tool on Population Level -
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joseph B. Ciolino, MD
Physician and Surgeon, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Associate Professor, Ophthalmology, Harvard Medical School
Recent Article
Developing Drug-Releasing Contact Lenses
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
